Asarina Pharma AB publ announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating loss was SEK 17.841 million compared to SEK 28.128 million a year ago. Net loss was SEK 20.679 million compared to SEK 25.820 million a year ago. Basic loss per share was SEK 1.1 compared to SEK 1.61 a year ago. Diluted loss per share was SEK 1.05 compared to SEK 1.53 a year ago. For the half year, operating loss was SEK 38.959 million compared to SEK 38.881 million a year ago. Net loss was SEK 39.048 million compared to SEK 35.250 million a year ago. Basic loss per share was SEK 2.09 compared to SEK 2.19 a year ago. Diluted loss per share was SEK 2 compared to SEK 2.1 a year ago.